日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial

紫杉醇纳米粒联合顺铂和卡培他滨与顺铂联合吉西他滨作为复发或转移性鼻咽癌患者一线化疗方案的比较：一项随机3期临床试验

期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2023-077890
Liu, Guo-Ying; Ye, Yan-Fang; Jiang, Yao-Fei; Chen, Gina Jinna; Xia, Wei-Xiong; Huang, Yi-Sheng; Gao, Tian-Sheng; Liu, Yi-Min; Hou, Ya-Ting; Li, Jian-Fei; Liu, Jia-Hao; Lu, Nian; Chen, Chang-Long; Ke, Liang-Ru; Liang, Hu; Bei, Wei-Xin; Li, Wang-Zhong; Dong, Shu-Hui; Liu, Qin; Xie, Changqing; Yao, He-Rui; Xiang, Yan-Qun
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

BRD7 inhibits tumor progression by positively regulating the p53 pathway in hepatocellular carcinoma

BRD7通过正向调控肝细胞癌中的p53通路抑制肿瘤进展

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.50293
Chen, Chang-Long; Mo, Hua-Qian; Jiang, Yan-Hui; Zhao, Xiao-Hui; Ma, Shuang; You, Kai-Yun; Pan, Yue; Liu, Yi-Min
肿瘤
肿瘤免疫
信号转导
BRD7
细胞生物学
发表日期：2021
文献求助 收藏

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.

PD-L1 表达是乳腺癌术后患者接受 CIK 细胞免疫疗法的预测性生物标志物

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0696-8
Zhou Zi-Qi, Zhao Jing-Jing, Pan Qiu-Zhong, Chen Chang-Long, Liu Yuan, Tang Yan, Zhu Qian, Weng De-Sheng, Xia Jian-Chuan
细胞生物学
乳腺癌
肿瘤免疫
发表日期：2019
文献求助 收藏

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

回顾性分析辅助性CIK细胞疗法对接受术后化疗的上皮性卵巢癌患者的疗效

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2018.1528411
Zhou, Yun; Chen, Chang-Long; Jiang, Sen-Wei; Feng, Yanling; Yuan, Linjing; Chen, Ping; Zhang, Lan; Huang, Shuting; Li, Jundong; Xia, Jian-Chuan; Zheng, Min
肿瘤免疫
卵巢癌
细胞生物学
肿瘤
发表日期：2019
文献求助 收藏

Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors

PD-1阻断激活的DC-CIK细胞在晚期实体瘤患者中的安全性和活性

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2017.1417721
Chen, Chang-Long; Pan, Qiu-Zhong; Weng, De-Sheng; Xie, Chuan-Miao; Zhao, Jing-Jing; Chen, Min-Shan; Peng, Rui-Qing; Li, Dan-Dan; Wang, Ying; Tang, Yan; Wang, Qi-Jing; Zhang, Zhi-Ling; Zhang, Xiao-Fei; Jiang, Li-Juan; Zhou, Zi-Qi; Zhu, Qian; He, Jia; Liu, Yuan; Zhou, Fang-Jian; Xia, Jian-Chuan
PD-1
细胞生物学
发表日期：2018
文献求助 收藏

Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort

局部晚期鼻咽癌患者每周一次与每三周一次顺铂联合调强放射治疗的疗效比较：一项基于大样本队列的倾向评分分析

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.26110
Zhu, Qian; Hu, Hao; Tang, Lin-Quan; You, Rui; Zhao, Jing-Jing; Weng, De-Sheng; Pan, Qiu-Zhong; Chen, Chang-Long; Zhou, Zi-Qi; Tang, Yan; Xia, Jian-Chuan
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis

辅助细胞因子诱导杀伤细胞免疫疗法对接受放化疗后II-IVB期鼻咽癌患者的临床疗效：倾向评分分析

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.25790
Zhao, Jing-Jing; Zhou, Shu; Chen, Chang-Long; Zhang, Hong-Xia; Zhou, Zi-Qi; Wu, Zheng-Rong; Liu, Yuan; Pan, Qiu-Zhong; Zhu, Qian; Tang, Yan; Xia, Jian-Chuan; Weng, De-Sheng
肿瘤
肿瘤免疫
鼻咽癌
细胞生物学
免疫/内分泌
发表日期：2018
文献求助 收藏

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

肿瘤免疫微环境中免疫检查点的调控及其在食管鳞状细胞癌中的预后意义

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S181949
Zhao, Jing-Jing; Zhou, Zi-Qi; Wang, Peng; Chen, Chang-Long; Liu, Yuan; Pan, Qiu-Zhong; Zhu, Qian; Tang, Yan; Weng, De-Sheng; Xia, Jian-Chuan
肿瘤
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌
发表日期：2018
文献求助 收藏

Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes

肿瘤细胞PD-L1表达是鼻咽癌患者（伴有肿瘤内浸润淋巴细胞）的良好预后因素

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2017.1312240
Zhu, Qian; Cai, Mu-Yan; Chen, Chang-Long; Hu, Hao; Lin, Huan-Xin; Li, Min; Weng, De-Sheng; Zhao, Jing-Jing; Guo, Ling; Xia, Jian-Chuan
肿瘤细胞
PD-L1
鼻咽癌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2017
文献求助 收藏

IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma

IL-17通过促进有益中性粒细胞的募集和活化，在食管鳞状细胞癌中诱导抗肿瘤免疫。

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2017.1373234
Chen, Chang-Long; Wang, Ying; Huang, Chun-Yu; Zhou, Zi-Qi; Zhao, Jing-Jing; Zhang, Xiao-Fei; Pan, Qiu-Zhong; Wu, Jiang-Xue; Weng, De-Sheng; Tang, Yan; Zhu, Qian; Yuan, Lu-Ping; Xia, Jian-Chuan
肿瘤
中性粒细胞
肿瘤免疫
IL-17
粒细胞
细胞生物学
免疫/内分泌
发表日期：2017
文献求助 收藏